William B. Horne bought $4,852 of ALZN
director at Alzamend Neuro, Inc.. 5,000 shares at an average of $0.97, traded Mar 18, 2025, filed Mar 19, 2025.
Score components
- +15RoleDirector
- 0Trade size$5k at market
- +6Relative to holdingsHoldings up 30%
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -29.5%, 3m -64.7%, 6m -70.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001214659-25-004545, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | MOption exercise Common Stock | +10,000 | $0.06 | $600 | 16,666 | Mar 19, 2025 |
| Mar 18, 2025 | POpen-market purchase Common Stock | +5,000 | $0.97 | $4,852 | 21,666 | Mar 19, 2025 |
| Mar 18, 2025 | MOption exercise Stock Options (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | Mar 19, 2025 |
Related signals
Other insiders at Alzamend Neuro, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | ALZNsell Alzamend Neuro, Inc. | Milton C Ault III director | $3,116 2,000 shares | -100% | |
| 38Weak | ALZNbuy Alzamend Neuro, Inc. | Milton C Ault III director | $111k 110,388 shares | +1336% | |
| 38Weak | ALZNbuy Alzamend Neuro, Inc. | Milton C Ault III director | $111k 110,388 shares | +1336% | |
| 38Weak | ALZNbuy Alzamend Neuro, Inc. | Milton C Ault III director | $109k 108,388 shares | +1312% | |
| 43Moderate | Alzamend Neuro, Inc. | Milton C Ault III director | $3,825 1,851 shares | -100% | |
| 43Moderate | Alzamend Neuro, Inc. | William B. Horne director | $7,059 3,333 shares | -100% | |
| 35Weak | ALZNsell Alzamend Neuro, Inc. | Lynne Fahey McGrath director | $69 30 shares | -55% | |
| 49Moderate | ALZNsell Alzamend Neuro, Inc. | Milton C Ault III director | $295k 121,791 shares | -94% | |
| 50Moderate | ALZNsell Alzamend Neuro, Inc. | Milton C Ault III director | $344k 139,412 shares | -129% | |
| 49Moderate | ALZNsell Alzamend Neuro, Inc. | Milton C Ault III director | $297k 123,366 shares | -94% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.